With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1204-75-7,3-Oxo-3,4-dihydroquinoxaline-2-carboxylic acid,as a common compound, the synthetic route is as follows.,1204-75-7
To a stirred solution of Cu(ClO4)2*6H2O (18.75 mg, 0.05mmol) in H2O (2 mL) was added 1 equiv. of pyrazine (4 mg,0.05 mmol) in CH3OH (5 mL). This was stirred for 5 min,and then a 5 mL CH3OH solution of 3-hydroxy-2-quinoxalinecarboxylic acid (9.5 mg, 0.05 mmol) wasadded to the reaction mixture and then filtered to givea green solution. Slow evaporation of the solvent atroom temperature gave rise to green block single crystals suitable for X-ray single-crystal analysis after ca 5 days. Yield: 40% (based on Cu). Anal. calcd forC22H20CuN6O10: C, 44.64; H, 3.41; N, 14.20%. Found: C,44.58; H, 3.49; N, 14.27%; IR (KBr)/cm-1: 3464(m),1683(s), 1609(m), 1374(m), 1326(m), 1221(w), 986(w),882(w), 806(w), 776(m), 676(m), 446(w).
As the paragraph descriping shows that 1204-75-7 is playing an increasingly important role.
Reference£º
Article; Liu, Qi; Wu, Huai Guang; Comptes Rendus Chimie; vol. 16; 5; (2013); p. 451 – 461;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider